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Abstract
Following a request from the European Commission, the Panel on Genetically Modiﬁed Organisms of
the European Food Safety Authority (GMO Panel) assessed the annual post-market environmental
monitoring (PMEM) report for the 2014 growing season of maize MON 810 provided by Monsanto
Europe S.A. The GMO Panel concludes that the insect resistance monitoring data do not indicate a
decrease in susceptibility of ﬁeld Iberian populations of corn borers to the Cry1Ab protein over the
2014 season. However, as the methodology for insect resistance monitoring remained unchanged
compared to previous PMEM reports, the GMO Panel reiterates its previous recommendations for
improvement of the insect resistance management plan. The GMO Panel considers that the farmer
alert system to report complaints regarding product performance could complement the information
obtained from the laboratory bioassays, but encourages the consent holder to provide more
information in order to be in a position to appraise its usefulness. The data on general surveillance
activities do not indicate any unanticipated adverse effects on human and animal health or the
environment arising from the cultivation of maize MON 810 cultivation in 2014. The GMO
Panel reiterates its previous recommendations to improve the methodology for the analysis of farmer
questionnaires and conduct of the literature review in future annual PMEM reports on maize MON 810.
The GMO Panel urges the consent holder to consider how to make best use of the information
recorded in national registers to optimise sampling for farmer questionnaires, and requests to continue
reviewing and discussing relevant scientiﬁc publications on possible adverse effects of maize MON 810
on rove beetles. Also, the GMO Panel encourages relevant parties to continue developing a
methodological framework to use existing networks in the broader context of environmental
monitoring.
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Summary
Following a request from the European Commission, the Panel on Genetically Modiﬁed Organisms of
the European Food Safety Authority (GMO Panel) assessed the annual post-market environmental
monitoring (PMEM) report on the cultivation of maize MON 810 during the 2014 growing season
provided by Monsanto Europe S.A.
The 2014 case-speciﬁc monitoring (CSM) dataset on maize MON 810 consists of a survey on
compliance with non-Bacillus thuringiensis (non-Bt) refugia in Spain and Portugal, and dose–response
and diagnostic dose bioassays to monitor for changes in susceptibility to Cry1Ab in target pests
(European and Mediterranean corn borer) collected from Iberian populations. The 2014 PMEM report
shows partial non-compliance with the implementation of non-Bt refugia in Spain as observed in
previous years. Therefore, the GMO Panel recommends that the consent holder consolidates its efforts
to increase the level of compliance, especially in regions of high maize MON 810 uptake, where such
compliance is crucial to ensure the effectiveness of the high-dose refuge strategy. The analyses of the
bioassays do not indicate a decrease in susceptibility to the Cry1Ab protein in the tested target pests
from the populations monitored in 2014.
The methodology for insect resistance monitoring remained unchanged compared to previous
PMEM reports. The GMO Panel reiterates its previous recommendations to improve of the insect
resistance management plan of maize MON 810, in particular, the recommendations to: (1) set a
minimum detection limit for resistance allele frequency at 3%, meaning that the minimum number of
ﬁeld larvae tested should be above ca. 1,000 in a given sampling area in those regions where the
adoption rates of maize MON 810 are above 60%; (2) implement annual monitoring of bi-/multivoltine
populations of both target pests in areas where adoption rate of maize MON 810 is at least 60%; and
(3) monitor target pest populations exclusively from North East Iberia (i.e. the Ebro valley), where ﬁeld
resistance to Cry1Ab is more likely to evolve.
The consent holder put a farmer alert system in place allowing farmers to report complaints
regarding product performance (including unexpected ﬁeld plant damage caused by target pests). The
GMO Panel cannot appraise the usefulness of the farmer alert system, which could complement the
information received from the laboratory bioassays, and considers that more information should be
provided to determine whether appropriate communication mechanisms and ﬁt-for-purpose
educational programmes are implemented that ensure the timely and effective reporting of farmer
complaints.
The 2014 general surveillance (GS) dataset on maize MON 810 consists of a survey based on 261
farmer questionnaires, peer-reviewed publications relevant to the risk assessment and/or
management of maize MON 810 (published between June 2014 and June 2015), and alerts on
environmental issues issued by regulatory authorities and existing surveillance networks. To identify
relevant publications not reported by the consent holder, the GMO Panel performed a literature search
and assessed the relevance of retrieved scientiﬁc publications for the safety of maize MON 810. The
available data do not indicate any unanticipated adverse effects on human and animal health or the
environment arising from the cultivation of maize MON 810 during the 2014 growing season.
Therefore, the GMO Panel considers that its previous conclusions on the safety of maize MON 810
remain valid and applicable. The consent holder is requested to continue screening, reviewing and
discussing relevant scientiﬁc publications on possible adverse effects of maize MON 810 on rove
beetles.
Methodological shortcomings similar to those found in previous annual PMEM reports on maize
MON 810 were identiﬁed in the analysis of farmer questionnaires and conduct of the literature review.
The GMO Panel therefore strongly reiterates its recommendations to provide more detailed information
on the sampling methodology, reduce the possibility of selection bias in farmer questionnaires and
ensure that all relevant scientiﬁc publications are identiﬁed. To improve the sampling frame of the
farmer survey, the GMO Panel reiterates the importance of national GMO cultivation registers and its
recommendations to consent holders to consider how they may make best use of the information
recorded in national registers and foster dialogue with those responsible for the administration of these
registers where maize MON 810 is cultivated.
No information collected from existing monitoring networks in the European Union (EU) was
provided by the consent holder. However, the GMO Panel notes that initiatives have been taken to
develop a methodological framework to use existing networks in the broader context of environmental
monitoring and encourages relevant parties to continue to use these.
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1. Introduction
The transformation event MON 810 has been introduced into a wide range of maize varieties that
have been cultivated in the European Union (EU) since 2003. Maize MON 810 produces the insecticidal
protein Cry1Ab from Bacillus thuringiensis (Bt), which confers resistance to certain lepidopteran pests,
such as the European corn borer (ECB), Ostrinia nubilalis (H€ubner) (Lepidoptera: Crambidae) and the
Mediterranean corn borer (MCB), Sesamia nonagrioides (Lefebvre) (Lepidoptera: Noctuidae). In 2014,
maize MON 810 was grown in Spain (137,537 ha), Portugal (8,542 ha), the Czech Republic (1,754 ha),
Romania (711 ha) and Slovakia (411 ha) over a total area of approximately 143,015 ha.
According to Articles 13 and 20 of Directive 2001/18/EC1, each notiﬁcation for placing on the
market of a genetically modiﬁed organism (GMO) shall contain a plan for monitoring in accordance
with Annex VII of the Directive. Similarly, according to Articles 5.5(b) and 17.5(b) of Regulation (EC)
No 1829/20032, each application for the placing on the market of a GMO or food/feed containing or
consisting of that GMO shall be accompanied by a monitoring plan for environmental effects
conforming with Annex VII to Directive 2001/18/EC. Annex VII was supplemented by notes providing
guidance on the objectives, general principles and design of the monitoring plan.3
Results of post-market environmental monitoring (PMEM) activities on the cultivation of maize
MON 810 in the EU are reported to the European Commission and the Member States on an annual
basis by Monsanto Europe S.A. (hereafter referred to as the consent holder). Since 2010, the Scientiﬁc
Panel on Genetically Modiﬁed Organisms of the European Food Safety Authority (hereafter referred to
as GMO Panel) assesses these annual PMEM reports on the cultivation of maize MON 810 (EFSA GMO
Panel, 2011a, 2012a, 2013, 2014a, 2015a,b).
1.1. Background and Terms of Reference provided by the requestor
The marketing of maize MON 810 (notiﬁcation C/F/95/12-02) was authorised under Directive
90/220/EEC in the EU for all, other than food, uses by the Commission Decision 98/294/EC of 22 April
1998.4 Consent was granted to the consent holder on 3 August 1998 by the Competent Authority of
France. Food uses of maize derivatives were notiﬁed according to Article 5 of the Novel Food
Regulation (EC) No 258/97 on 6 February 1998.
Following the request by the consent holder for the renewal of the authorisation for placing maize
MON 810 on the market, the GMO Panel adopted a scientiﬁc opinion on the renewal under Regulation
(EC) No 1829/2003 of maize MON 810 for: existing food and food ingredients produced from maize
MON 810; feed consisting of and/or containing maize MON 810, including the use of seed for
cultivation; and food and feed additives, and feed materials produced from maize MON 810 (EFSA,
2009). The GMO Panel concluded that maize MON 810 is as safe as its conventional counterpart with
respect to potential effects on human and animal health, and that maize MON 810 is unlikely to have
any adverse effect on the environment in the context of its intended uses, especially if appropriate
management measures are put in place in order to mitigate possible exposure of non-target (NT)
Lepidoptera. The GMO Panel recommended that especially in areas of abundance of NT Lepidoptera
populations, the adoption of the cultivation of maize MON 810 be accompanied by management
measures in order to mitigate the possible exposure of these species to maize MON 810 pollen. In
addition, the GMO Panel advised that resistance management strategies continue to be employed and
that the evolution of resistance in lepidopteran target pests continues to be monitored, in order to
detect potential changes in resistance levels in pest populations (EFSA, 2009).
From 2005 onwards, the consent holder submitted to the European Commission its PMEM reports
on the cultivation of maize MON 810 according to the provisions of Directive 2001/18/EC. These
annual PMEM reports are composed of case-speciﬁc monitoring (CSM), to assess the efﬁcacy of the
‘high-dose/refuge’ strategy, and general surveillance (GS), to detect unanticipated adverse effects
caused by the cultivation of maize MON 810.
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1 Directive 2001/18/EC of the European Parliament and of the Council of 12 March 2001 on the deliberate release into the
environment of genetically modiﬁed organisms and repealing Council Directive 90/220/EEC. OJ L 106, 17.4.2001, p. 1–39.
2 Regulation (EC) No 1829/2003 of the European Parliament and of the Council of 22 September 2003 on genetically modiﬁed
food and feed. OJ L 268, 18.10.2003, p. 1–23.
3 Council Decision 2002/811 of 3 October 2002 establishing guidance notes supplementing Annex VII to Directive 2001/18/EC of
the European Parliament and of the Council on the deliberate release into the environment of genetically modiﬁed organisms
and repealing Council Directive 90/220/EEC. OJ L 280, 18.10.2002, p. 27–36.
4 Commission Decision of 22 April 1998 concerning the placing on the market of genetically modiﬁed maize (Zea mays L. line
MON 810), pursuant to Council Directive 90/220/EEC (98/294/EC). OJ L 131, 5.5.1998, p. 32–33.
Since 2010, the European Commission requested the GMO Panel to assess the annual PMEM
reports on the cultivation of maize MON 810 submitted by the consent holder. The GMO
Panel therefore adopted scientiﬁc opinions on the 2009, 2010, 2011, 2012, 2013 and revised 2013
annual PMEM reports (EFSA GMO Panel, 2011a, 2012a, 2013, 2014a, 2015a,b). From the data
provided in the previous annual PMEM reports, the GMO Panel did not identify adverse effects on
human and animal health and the environment resulting from the cultivation of maize MON 810.
However, the GMO Panel noted shortcomings in the methodology for CSM and GS, and made
recommendations to improve future annual PMEM reports on maize MON 810.
On 22 May 2012, the European Commission requested EFSA to compile an inventory of existing
environmental surveillance networks at the European level and at the National level, and develop a set
of assessment criteria to support the selection of such networks for PMEM of GM plants. Following this
request, an external open call was launched by the EFSA Unit for Assessment and Methodological
Support (hereafter referred to as AMU Unit). The external report reviewed statistical methods used in
the analysis of ecological and environmental datasets; provided an inventory of statistical approaches
in ecological and environmental monitoring and identiﬁcation of data requirements for the items in the
inventory; provided an inventory of European, National and Regional existing surveillance networks/
programmes; and gave recommendations of the most appropriate analysis methodologies for PMEM of
agroecosystems (Centre for Ecology and Hydrology et al., 2014).
On 24 March 2015, the European Commission requested EFSA to assess the concerns raised by the
consent holder about the GMO Panel recommendations on the insect resistance management (IRM)
strategy for maize MON 810 (EFSA GMO Panel, 2011a, 2012a, 2013, 2014a, 2015a). EFSA concluded
that the previous conclusions and recommendations by the GMO Panel remain valid (EFSA, 2015a).
On 2 September 2015, the European Commission received from the consent holder the monitoring
report for the 2014 cultivation season of maize MON 810.
On 26 October 2015, the European Commission requested the GMO Panel to assess the 2014
monitoring report and, in particular, to evaluate the ﬁndings of the monitoring activities, taking into
consideration the comments received from the Member States and to assess the appropriateness of
the methodology if this is found to differ compared to the previous season.
On 18 December 2015, the National Committee of Biosafety of the Spanish Competent Authority
sent in several considerations about EFSA’s recommendations on the IRM plan for maize MON 810.5
On 21 January 2016, the consent holder was invited as a hearing expert to a meeting of the PMEM
Working Group to provide clariﬁcations on the methodology of the monitoring activities which are part
of the IRM strategy of maize MON 810 and are described in the 2014 monitoring report.6
On 3 February 2016, the European Commission requested the GMO Panel to assess an additional
scientiﬁc publication (Zeljenkova et al., 2014) forwarded by the consent holder to be part of the annual
2014 PMEM report of maize MON 810.
2. Data and methodologies
2.1. Data
In delivering this scientiﬁc opinion, the GMO Panel took into account the information on CSM and
GS activities provided by the consent holder:
• an IRM plan,7 which is based on the ‘high-dose refuge strategy’, and that includes (1) surveys
on farmers’ compliance with non-Bt refugia, (2) the monitoring for changes in baseline
susceptibility of target pests and diagnostic dose8 assays,9 (3) a plan for communication with
farmers, and (4) a remedial action plan in the event of any conﬁrmed evolution of pest
resistance;
• a survey based on 261 questionnaires received from farmers in two European countries:10 213
in Spain and 48 in Portugal;
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5 http://registerofquestions.efsa.europa.eu/roqFrontend/questionDocumentsLoader?question=EFSA-Q-2015-00650 (Accessed: 4
March 2016).
6 http://www.efsa.europa.eu/sites/default/ﬁles/gmopmemreports2016.pdf (Accessed: 4 March 2016).
7 Annual 2014 PMEM report, Appendix 6.
8 The diagnostic dose is the dose that causes 99% of moulting inhibition (MIC99) to ﬁrst instars.
9 Annual 2014 PMEM report, Appendixes 7 and 8.
10 Annual 2014 PMEM report, Appendix 1.
• an assessment of 26 peer-reviewed publications relevant to the risk assessment and/or
management of maize MON 810, which were published between June 2014 and the beginning
of June 2015;11
• company stewardship activities;12 and
• alerts on environmental issues by regulatory authorities and existing surveillance networks.
In addition, the GMO Panel assessed additional relevant peer-reviewed papers published between
June 2014 and the beginning of June 2015 that were not included in the annual 2014 PMEM report
supplied by the consent holder.
2.2. Methodologies
Following the terms of reference of the EC mandate, the GMO Panel considered whether the
methodology applied to monitor maize MON 810 during the 2014 growing season differs from that
followed in the previous PMEM reports on maize MON 810 (EFSA GMO Panel, 2011a, 2012a, 2013,
2014a, 2015a,b).
The GMO Panel assessed the 2014 CSM and GS dataset on maize MON 810 (see Section 3).
In addition, the GMO Panel performed a systematic literature search to identify relevant scientiﬁc
publications not reported by the consent holder, and subsequently assessed their relevance for the risk
assessment and/or risk management of maize MON 810.
In its assessment, the GMO Panel also considered the comments from the Member States on the
annual 2014 PMEM report.13
3. Assessment
3.1. Implementation of non-Bt refugia
The GMO Panel analysed the results of the farmer questionnaires addressing the implementation of
non-Bt refugia.14 The consent holder asked 261 farmers from Spain and Portugal, the two main EU
countries where maize MON 810 was cultivated in 2014, to complete a questionnaire on the planting
of non-Bt refugia. In Spain, 178 out of 189 farmers (94%) growing maize MON 810 planted non-Bt
refugia. The 11 farmers that did not plant a refuge provided the following two reasons for their non-
compliance (as indicated in the survey): (1) the farmer had no or not enough information about the
technical guidelines (seven farmers) and (2) the sowing is complicated by planting a refuge (four
farmers). In Portugal, all maize MON 810-growing farmers surveyed (48) conﬁrmed to have planted
non-Bt refugia. Full compliance with refugia requirements by Portuguese farmers was also reported in
previous years.
The results of the Spanish farmer’s survey of 2014 could not be corroborated by a study carried out
by Antama,15 the Spanish Foundation supporting the use of new technologies in agriculture, as the
Antama survey was only conducted until 2012 (see Table 1).
In 2014, the Portuguese authorities performed inspections at 81 farms (out of the 238 notiﬁcations
received in 2014) cultivating maize MON 810 to check compliance with the requirements for the
cultivation of GM varieties outlined in Portuguese law. Based on the performed inspections, the
Portuguese authorities concluded that there was full compliance with refuge implementation.
The 2014 PMEM report shows partial non-compliance with the implementation of non-Bt refugia in
Spain as observed in previous years (Table 1). Therefore, the GMO Panel recommends that the
consent holder consolidates its efforts to increase the level of compliance, especially in regions of high
adoption rate of maize MON 810,16 where such compliance is crucial to ensure the effectiveness of the
high-dose refuge strategy. In this context, the education and training programme of the farming
community in managing maize MON 810 as proposed by the consent holder17 is essential to delay
resistance evolution in target pests.
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11 Annual 2014 PMEM report, Appendices 5.1-revised and 5.2.
12 Annual 2014 PMEM report, Appendices 3.1–3.5.
13 Comments were received from Austria, Germany, Hungary, Italy, Spain and the Netherlands.
14 The harmonised IRM plan states that no refuge is required for farmers planting less than 5 ha of maize MON 810 in the farm.
15 Spanish foundation supporting the use of new technologies in agriculture: http://fundacion-antama.org (Accessed: 4 March
2016).
16 The adoption rate of maize MON 810 is expressed as a fraction of total maize cultivation in the same geographical area.
17 Annual 2014 PMEM report, Section 3.2.1.3.
3.2. Susceptibility of Iberian ﬁeld populations of Ostrinia nubilalis and
Sesamia nonagrioides to Cry1Ab
3.2.1. Field sampling of target pests and laboratory assays
In line with EuropaBio’s harmonised IRM plan, which aims to collect target pest larvae from three
areas (i.e. North East, Central and South West Iberia) every 2 years, the ECB and MCB larvae were
collected in 2014 from refuges and ﬁelds of conventional maize adjacent to maize MON 810 ﬁelds in
two different geographical areas of the Iberian Peninsula (i.e. Central and South West Iberia). In
accordance with the EuropaBio’s harmonised IRM plan, no samples were collected in 2014 from North
East Iberia, although this is the area with the highest adoption level of cultivation of MON 810
(Table 2).
A total of 353 ECB last-instars were collected from two ﬁelds in South West Iberia and 479 and 644
MCB last-instars were collected from two ﬁelds in Central Iberia and from ﬁve ﬁelds in South West
Iberia, respectively (Table 3).
Dose–response and diagnostic dose laboratory assays were conducted to assess the susceptibility
to the Cry1Ab protein of the ECB and MCB populations, using neonate larvae of the subsequent
generation reared under laboratory conditions (F1). The neonates were exposed to puriﬁed Cry1Ab
protein. In addition, all surviving MCB larvae from both bioassays (1,650) and those neonates that
were not used in the bioassays (ca. 3,000) were fed MON 810 leaves ad libitum for 12 days and their
survival was assessed.
Table 1: Non-Bt refugia compliance by Spanish farmers between 2009 and 2014 from two sources
Growing
season
No. farmers
surveyed(a)
Compliance
(%) Source
(b)
2009 93 91 FQ
100 81 Antama
2010 142 91 FQ
100 88 Antama
2011 140 96 FQ
100 93 Antama
2012 154 84 FQ
100 93 Antama
2013 190 87 FQ
2014 189 94 FQ
(a): For the FQ, only farmers who were required to plant a refuge were considered for the calculation of non-Bt refugia
compliance.
(b): FQ: farmer questionnaires; Antama: Study conducted by Spanish foundation supporting the use of new technologies in
agriculture between 2009 and 2014.
Table 2: Area and adoption rate of maize MON 810 in North East Iberia (Aragon and Catalu~na, i.e.
Ebro valley), Central Iberia (Albacete) and South West Iberia (Extremadura and Andalucıa)
between 2010 and 2014 from two sources
Season
Area maize
MON 810 (ha)(a)
Source
Avances(b) ESYRCE(c)
Total maize
(ha)
Adoption
rate (%)
Total maize
(ha)
Adoption
rate (%)
North East Iberia
2010 56,910 93,162 61.1 124,386 45.8
2011 71,000 113,299 62.7 125,697 56.5
2012 75,200 108,621 69.2 107,564(d) 69.9
2013 88,447 125,293 70.6 119,859(d) 73.8
2014 90,421 126,628(e) 71.4 141,218 64.0
2010–2014 – – 67.0 – 62.0
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3.2.2. Insect bioassays to assess Cry1Ab susceptibility
3.2.2.1. Dose–response bioassays
The consent holder monitored possible changes in baseline susceptibility to the Cry1Ab protein of the
target pest populations of South West Iberia (for both ECB and MCB) and Central Iberia (for MCB only) by
measuring the moulting inhibiting concentrations (MIC50 and MIC90) in dose–response bioassays.
Season
Area maize
MON 810 (ha)(a)
Source
Avances(b) ESYRCE(c)
Total maize
(ha)
Adoption
rate (%)
Total maize
(ha)
Adoption
rate (%)
Central Iberia
2010 2,695 11,005 24.5 12,455(d) 21.6
2011 5,041 15,718 32.1 15,967(d) 31.6
2012 6,453 17,701 36.5 19,297(d) 33.4
2013 6,564 16,950 38.7 20,698(d) 31.7
2014 5,696 14,700(e) 38.8 16,585(d) 34.3
2010–2014 – – 34.1 – 30.5
South West Iberia
2010 11,543 65,030 17.8 73,910 15.6
2011 15,811 85,295 18.5 94,621 16.7
2012 26,313 101,649 25.9 118,039(d) 22.3
2013 31,058 113,437 27.4 123,097(d) 25.2
2014 24,507 114,358(e) 21.4 108,574 22.6
2010–2014 – – 22.2 – 20.5
(a): Source:http://www.magrama.gob.es/es/calidad-y-evaluacion-ambiental/temas/biotecnologia/organismos-modiﬁcados-
geneticamente-omg-/consejo-interministerial-de-ogms/superﬁcie.aspx (Accessed: 4 March 2016).
(b): Avances de superﬁcies y producciones de cultivos: http://www.magrama.gob.es/es/estadistica/temas/estadisticas-agrarias/
agricultura/avances-superﬁcies-producciones-agricolas/ (Accessed: 4 March 2016).
(c): Encuesta sobre superﬁcies y rendimieto de cultivos (ESYRCE): http://www.magrama.gob.es/es/estadistica/temas/estadisticas-
agrarias/agricultura/esyrce/ (Accessed: 4 March 2016).
(d): Data for maize as a second crop were not included.
(e): Provisional data.
Table 3: Field collection of Ostrinia nubilalis (ECB) and Sesamia nonagrioides (MCB) larvae in the
2014 growing season in different areas of the Iberian Peninsula
Target pest
Geographical
area
Field (Province – Country)
No. larvae
collected
ECB South West Iberia Merida (Badajoz – SP) 246
Elvas (PO) 107
Total 353
MCB Central Iberia(a) La Gineta (Albacete – SP) 277
Motilleja (Albacete – SP) 202
Total 479
South West Iberia(b) Merida (Badajoz – SP) 7
Sanlucar de Barrameda (Cadiz – SP) 216
El Batan (Caceres – SP) 248
Logrosan (Caceres – SP) 24
Miajadas (Caceres – SP) 149
Total 644
PO: Portugal; SP: Spain.
(a): Two additional ﬁelds were inspected but larvae were not found.
(b): Five additional ﬁelds were inspected but larvae were not found.
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The MIC50 and MIC90 values reported in 2014 for the ECB populations are lower compared to
previous years (Table 4), while those for the MCB populations are in the range of the MIC50 and MIC90
values obtained in previous years (Table 5).
The consent holder concluded that the differences found in the susceptibility to the toxin are within
the range of variability expected for ﬁeld collections of these corn borers. Further, the analyses of
historical series of susceptibility data of S. nonagrioides or O. nubilalis to Cry1Ab did not reveal signs
of changed susceptibility to this toxin by ﬁeld collections from the sampling the [sic] areas considered.
Table 4: Susceptibility to Cry1Ab protein of South West Iberian ﬁeld populations of Ostrinia nubilalis
(ECB) collected in refuge areas and/or ﬁelds of conventional maize adjacent to maize
MON 810 ﬁelds
Population
Growing
season
No. larvae
collected
(no. ﬁelds)
Protein
batch(a)
MIC50
(95 % CI)(b)
MIC90
(95 % CI)(b)
RR
MIC50
(c)
RR
MIC90
(c)
South West
Iberia
2008 430 (3) B1 3.39
(2.94–3.89)
6.90
(5.79–8.89)
4.24 2.38
2010 548 (3) B1 5.76
(4.38–7.84)
11.85
(8.53–23.52)
2.88 1.77
2012 378 (2) B2 4.08
(2.99–5.50)
8.69
(6.30–15.56)
3.71 3.48
2014 353 (2) B3 1.32
(0.94–1.74)
3.80
(2.78–6.21)
0.41 0.28
CI: conﬁdence interval.
(a): Data provided by the consent holder showed that the Cry1Ab protein batches B1 and B2, and B2 and B3 have similar
insecticidal activity.
(b): 50% and 90% moulting inhibition concentration (MIC50 and MIC90) and their 95% conﬁdence intervals (CI 95%) are
expressed in ng Cry1Ab/cm2.
(c): Resistance ratio (RR) between MIC values of the ﬁeld-collected populations and of the susceptible laboratory strain for each
growing season.
Table 5: Susceptibility to Cry1Ab protein of South West Iberian ﬁeld populations of Sesamia
nonagrioides (MCB) collected in refuge areas and/or ﬁelds of conventional maize adjacent
to maize MON 810 ﬁelds
Population
Growing
season
No. larvae
collected
(no. ﬁelds)
Protein
batch(a)
MIC50
(95% CI)(b)
MIC90
(95% CI)(b)
RR
MIC50
(c)
RR
MIC90
(c)
Central
Iberia
2004 n.a. B1 12 (5–22) 248 (143–588) 0.67 2.50
2006 n.a. B1 7 (1–17) 321 (157–1360) n.a. n.a.
2008 320 (4) B1 28 (18–38) 170 (124–259) 1.47 1.42
2010 570 (3) B1 10 (6–14) 119 (81–200) 1.25 1.61
2012 544 (3) B2 15 (8–25) 160 (79–608) 2.14 2.58
2014 479 (2) B3 15 (9–21) 138 (81–329) 0.88 1.52
South West
Iberia
2005(d) n.a. B1 16(e) 30(e) n.a. n.a.
2005(f) n.a. B1 8 (3–16) 152 (94–309) n.a. n.a.
2007 717 (3) B1 17 (10–25) 223 (153–385) 1.06 2.37
2010 164 (2) B1 16 (11–21)(g) 86 (60–141)(g) 2.00 1.16
2012 243 (5) B2 29 (19–1) 158 (101–339) 4.14 2.55
2014 644 (5) B3 31 (23–43) 236 (140–569) 1.82 2.59
n.a.: data not available; CI: conﬁdence interval.
(a): Bridging studies showed that the Cry1Ab protein batches B1 and B2, and B2 and B3 have similar insecticidal activity.
(b): 50% and 90% moulting inhibition concentration (MIC50 and MIC90) and their 95% conﬁdence intervals (CI 95%) are
expressed in ng Cry1Ab/cm2.
(c): Resistance ratio (RR) between MIC values of the ﬁeld-collected populations and the susceptible laboratory strain for each
growing season.
(d): Larvae collected in Spain.
(e): 95% CI could not be estimated because the coefﬁcient g was > 0.5 at the 95% probability level.
(f): Larvae collected in Portugal.
(g): Bioassays were performed with the F2 generation due to the low number of ﬁeld larvae collected.
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3.2.2.2. Diagnostic dose assays
The diagnostic dose assays were performed with both the ECB and MCB populations collected in
2014, respectively, using a dose of 28.2218 and 72619 ng Cry1Ab/cm2.
Moult inhibition of the ECB larvae collected in South West Iberia was 100% as no single larvae
survived after 7 days of exposure. For the MCB larvae, moult inhibition was 96  2% and 96  1%
(mean  SE) for Central and South West Iberian populations, respectively.
3.2.2.3. Survival of MCB larvae fed maize MON 810 leaves
None of the MCB larvae fed maize MON 810 leaves survived after 12 days of exposure.
The bioassay with MON 810 leaves was used by the consent holder to further prove the absence of
resistant individuals in the progenies obtained from ﬁeld-collected larvae. As maize MON 810 is
expected to cause 100% mortality of heterozygotes, this bioassay reinforces the results obtained in
the diagnostic dose assay. However, to correctly interpret the results, additional information (e.g. lethal
time (LT50), developmental stage at death, Cry1Ab protein expression in detached leaves) should be
made available.
3.2.3. Conclusions of the assessment of Cry1Ab susceptibility
The GMO Panel did not identify changes in the methodology compared with the 2013 annual PMEM
report. However, the GMO Panel recommends that further details on the methodology followed in the
dose–response and diagnostic dose assays (e.g. preimaginal mortality of ﬁeld-collected larvae, number
of adults mated to obtain F1 larvae, number of individuals screened and number of replicates used in
the diagnostic dose assay) should be provided by the consent holder for an appropriate appraisal of
the methodology and for a more precise estimation of the detection limit of the resistance allele
frequency.
In the 2014 PMEM report, only MIC values were provided. The GMO Panel agrees that
measurements of sublethal effects proved in some cases to be more sensitive than mortality for
natural toxins (e.g. Schmutterer, 1990), including Cry proteins (e.g. Lovei et al., 2009). However, both
lethal and sublethal measurements provide useful information for detecting possible adverse effects.
Therefore, the GMO Panel reiterates its previous recommendation to provide both LC (lethal
concentration) and MIC values in future PMEM reports (EFSA GMO Panel, 2012a).
The GMO Panel concludes that the analyses of the 2014 dataset provided by the consent holder do
not indicate a decrease in susceptibility to the Cry1Ab protein in the tested target pests from those
Iberian populations that were monitored in 2014. As the populations tested in 2014 came from areas
of low adoption rate of maize MON 810 (Table 2) and, thus, of low selection pressure, this conﬁrms
the assumptions made during the initial risk assessment, i.e. that resistance is unlikely to evolve
in situations of low adoption of maize MON 810. The GMO Panel reiterates its previous
recommendation to focus sampling in areas of high adoption rate of maize MON 810 (EFSA, 2015a)
(for further information, see Section 3.2.4).
The GMO Panel is not aware of any scientiﬁc report on the detection of ﬁeld resistance to Cry1Ab in
the ECB and MCB populations in the EU.
3.2.4. Further considerations on the harmonised IRM plan
The purpose of the IRM plan is to maintain the effectiveness of Bt crops as an insect pest
management tool by preventing or delaying the evolution of resistance to Bt traits in the target pests.
For maize MON 810, the consent holder follows EuropaBio’s harmonised IRM plan for cultivation of
Bt-maize (single insecticidal trait) in the EU. For maize MON 810 grown in the EU, this plan foresees
resistance monitoring of ECB and MCB populations in the Iberian Peninsula.
3.2.4.1. Detection of resistance allele frequency
The harmonised IRM plan states that the methodology followed by the consent holder to assess
changes in susceptibility to Cry1Ab is able to detect resistance when resistance allele frequency
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18 The diagnostic dose was based on the MIC99 value obtained from data of the ECB larvae collected in ﬁelds from the Czech
Republic, France, Germany, Italy, Panonia, Poland, Portugal, Romania and Spain between 2005 and 2012.
19 The diagnostic dose was based on the MIC99 value obtained from data of the MCB larvae collected in ﬁelds from South West,
Central and North East Iberia between 2008 and 2012.
reaches 1–5%. The level of resistance allele frequency that one can detect will determine the time left
to implement remedial measures before ﬁeld resistance occurs.20
In its technical report (EFSA, 2015a), EFSA conducted new model simulations for the ECB
populations using the Populus model to estimate the number of generations required to reach a
resistance allele frequency of 50% in the target insect population, once the allele frequency detected
during CSM has reached 1%, 3% or 5% (Table 6).21 In these simulations, two adoption rates of maize
MON 810 (i.e. 60% and 80%) and three values for density-dependent mortality (0.3, 0.5 and 0.7)
were considered. For instance, in a geographical area where adoption of maize MON 810 is 60%, a
detection level of 3% resistance allele frequency will leave seven generations (i.e. 3.5 years for
populations in the Ebro valley, see Velasco et al., 2007) before ﬁeld resistance is achieved, considering
a density-dependent mortality estimate of 0.7, which is the most conservative estimate used in the
simulations (Table 6).
The GMO Panel acknowledges that all simulation exercises are subject to scientiﬁc uncertainty. The
major sources of variability in the above predictions of the number of generations arise from
assumptions made in the model structure and the incomplete availability of data. However, the GMO
Panel notes that there is a widespread acceptance by all stakeholders that once allele frequency
approaches close to 1%, the rate of evolution of resistance is very rapid and the implementation of
mitigation measures becomes urgent if ﬁeld resistance is to be delayed.
Therefore, based on the outcome of the model simulations, and considering the time needed to
implement appropriate mitigation measures before pest populations become resistant (for more
information, see EFSA GMO Panel, 2013), the GMO Panel considers that a detection level of 1% would
be an appropriate threshold, as it allows more time to undertake measures and offers more options to
mitigate the potential for ﬁeld resistance to evolve than a level of 3%.
However, the GMO Panel acknowledges that limitations exist for sampling adequate numbers of
target pests in the ﬁelds. For instance, when no resistant individual is observed in a diagnostic dose
assay, it is necessary to screen ca. 10,000 larvae to conclude that the actual resistance allele
frequency is below 1% in a target pest population, and it could be difﬁcult to sample that many larvae
in a given sampling area. It should also be considered that larvae must be reared and mated before
testing (i.e. F1 larvae are tested) and that several additional factors, like the preimaginal mortality
during the laboratory rearing, need to be considered to determine the appropriate sample size of ﬁeld-
collected larvae. Therefore, the GMO Panel considers that a threshold of 3% is the maximum detection
level that must be achieved in practice, meaning that the minimum number of ﬁeld larvae tested
should be above ca. 1,000 in each sampling area. If achievable, a lower detection limit should be
aimed at by the consent holder. Although not currently used on a routine basis due to technical
limitations, F2 screening could be considered as an alternative testing approach, because it requires
less larvae than the diagnostic dose assay (Andow and Ives, 2002).
The GMO Panel considers that a detection level of 5% resistance allele frequency would not leave
sufﬁcient time to undertake action to prevent the development of ﬁeld resistance.
Table 6: Minimum number of generations before 50% resistance allele frequency (threshold for
resistance in a population) in Ostrinia nubilalis (ECB) populations is reached from the
detection of an allele frequency of 1%, 3% and 5%, according to model simulations by
EFSA (2015a) using the Populus model. Calculations are reported for a density-dependent
mortality estimate of 0.7
Adoption rate of
maize MON 810
Minimum number of generations(a) before resistance occurs
Detection of resistance allele frequency
1% 3% 5%
60% 13 7 5
80% 12 6 5
(a): In the Ebro valley, O. nubilalis populations complete two generations per year (Velasco et al., 2007).
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20 A target pest population is considered resistant when the resistance allele frequency has reached 0.5 (or 50%).
21 The parameters (and values) entered for the simulations with the Populus model were: adoption rate of maize MON 810 (60%
and 80%); density-dependent mortality (0.3, 0.5 and 0.7); initial allele frequency (0.006, see Engels et al., 2010); fecundity
(100); dominance (0.01 – almost fully recessive); preference for Bt-maize in the second generation (120%); overwinter
survival (0.01): and survival of susceptible homozygotes on Bt (0.001).
3.2.4.2. Sampling frequency
The sampling frequency of the ECB and MCB populations proposed by the consent holder and
recommended by the GMO Panel is determined by the adoption rate of maize MON 810 in a
geographical area and the voltinism (i.e. number of generations in a year)22 of the pests in that area.
Following its harmonised IRM plan, the consent holder proposed to sample target pest populations
every 2 years in areas where adoption rate varies between 20% and 80% of the total maize cultivated
area, and only to sample annually in case of multivoltine populations in areas where adoption rate is
higher than 80%. Based on simulations using the Populus model developed by Alstad and Andow
(1995)23 (for more details see EFSA, 2015a), the GMO Panel recommends annual sampling of
bi-/multivoltine target pests when adoption rate is higher than 60% in order to ensure an early detection
of change in susceptibility of the ECB and MCB ﬁeld populations (Table 7). Conversely, the GMO
Panel considers that it is not necessary to monitor areas where adoption rate is lower than 20%.
The average adoption rate of maize MON 810 in the Ebro valley between 2009 and 2014 has been
ca. 65% (Table 2). Because the ECB and MCB populations can complete two generations per year (i.e.
they are both bivoltine) in north Spain (Velasco et al., 2007), the GMO Panel recommends that the
consent holder samples both target pests annually in that particular geographical area.
3.2.4.3. Sampling areas and zones
In its harmonised IRM plan, the consent holder stated that the sampling will be intensiﬁed in areas
where high levels of Bt-maize adoption occur and where target pest pressure is higher. Currently, the
ECB and MCB populations are sampled in three different geographical areas of the Iberian Peninsula,
i.e., North East, Central and South West Iberia. Instead, the GMO Panel reiterates its recommendation
to focus the sampling effort exclusively in North East Iberia (i.e. the Ebro valley), where adoption rates
of maize MON 81024 have been the highest in the Iberian Peninsula since 2003,25 because ﬁeld
resistance to Cry1Ab is more likely to evolve in areas where the selection pressure is the highest.
In its technical report on the IRM plan for maize MON 810 (EFSA, 2015a), EFSA recommended
that, in order to capture variability in sensitivity, the ECB and MCB larvae should be collected from
three sampling zones of approximately 10 km 9 10 km within the Ebro valley, where adoption rate of
maize MON 810 is higher than 50% for at least three consecutive years. The GMO Panel recognises
that, in some cases, the collection of sufﬁcient number of larvae in zones of 10 km 9 10 km is not
feasible. In these cases, samples can be collected from larger zones, provided that justiﬁcation is given
for this deviation.
The GMO Panel acknowledges that it may be difﬁcult for the consent holder to acquire information
on maize MON 810 cropping areas in the absence of a national GMO register that records all maize
MON 810 cultivation. The GMO Panel therefore reiterates the importance for the Member States to
implement registers of GM crop cultivation.
Table 7: Sampling frequency of ﬁeld populations of Ostrinia nubilalis (ECB) and Sesamia
nonagrioides (MCB) recommended by the GMO Panel
Adoption rate of
maize MON 810
Monovoltine
populations(a)
Bi-/Multivoltine
populations(b)
> 60–80% Biennial Annual
> 80%(c) Annual Annual
Current situation for adoption rate of maize MON 810 and voltinism of target pests in the Ebro valley is shown in bold.
(a): A monovoltine population is a population producing one generation in a year.
(b): A bivoltine population is a population having two generations in a year. This is the case for the ECB and MCB populations in
the Ebro valley. A multivoltine population is a population having several generations in a year.
(c): In circumstances in which non-Bt-maize refugia have not been fully implemented.
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22 The terms univoltine, bivoltine and multivoltine refer to insects having one, two or more than two generations per year,
respectively.
23 http://cbs.umn.edu/populus/overview (Accessed: 4 March 2016).
24 At the time of adoption of this opinion, maize MON 810 is the only Cry1-expressing maize cultivated in the EU. However, the
GMO Panel recommends that in future the consent holder takes into consideration the overall adoption rate of Cry1-expressing
maize when identifying zones of high adoption for sampling target pests.
25 Source:http://www.magrama.gob.es/es/calidad-y-evaluacion-ambiental/temas/biotecnologia/organismos-modiﬁcados-
geneticamente-omg-/consejo-interministerial-de-ogms/superﬁcie.aspx (Accessed: 4 March 2016).
In addition, the GMO Panel recommends that geographical coordinates of each sampling site are
given in future annual PMEM reports.
In the current sampling protocol followed by the consent holder, samples from the three sampling
zones within a geographical zone are pooled. However, the GMO Panel recommends that the data
from samples taken in different sampling zones should be analysed separately in order to detect
potential interpopulation variation in the susceptibility of target pest populations (EFSA GMO Panel,
2012a) and to make it more sensitive to possible resistance evolution over time in a given sampling
zone.
3.2.4.4. Farmer alert system
The GMO Panel notes that the consent holder put a farmer alert system in place allowing farmers
to report complaints regarding product performance (including unexpected ﬁeld plant damage caused
by target pests). The information gathered through this channel could complement the information
obtained in the laboratory bioassays. However, due to lack of information on this alert system, the
GMO Panel is not in a position to appraise its usefulness. The GMO Panel considers that the consent
holder should provide more information on the farmer alert system in their future annual PMEM reports
(e.g. number and type of complaints, how complaints referring to potential lack of efﬁcacy of maize
MON 810 are followed up by the consent holder, how complaints to other consent holders marketing
maize MON 810 are collated and analysed).
The consent holder states that not a single MON 810 performance complaint allegedly caused by
reduced target pest susceptibility was received from farmers in 2014.
3.3. Farmer questionnaires
In its annual 2014 PMEM report, the consent holder submitted a survey completed between
December 2014 and March 2015 based on 261 questionnaires received from farmers in two European
countries: 213 in Spain and 48 in Portugal. No farmers from the Czech Republic, Romania and
Slovakia, representing 2% of the maize MON 810 grown in the EU in 2014, were interviewed. The
consent holder concluded that the analysis of the questionnaires did not identify any potential adverse
effects that might be related with to MON 810 plants and their cultivation.
The GMO Panel, in close collaboration with the AMU Unit, assessed the methodology followed by
the consent holder to analyse the farmer questionnaires. Alongside the methodological guidance for a
systematic evaluation of farmer questionnaires, the evaluation of the overall 2014 farmer’s survey
(including, for example, sampling of farmers, types of questions, method of conduct interviews, data
validation, method used for the design of the statistical analysis) is given in Annex A.
The methodology, consisting of the use of farmer questionnaires, followed by the consent holder to
identify unanticipated adverse effects caused by the cultivation of maize MON 810 did not differ from
previous annual PMEM reports (EFSA GMO Panel, 2011a, 2012a, 2013, 2014a, 2015b). Similar
weaknesses in the methodology as in previous annual PMEM reports were observed, and
recommendations to the consent holder for the improvement of the methodology are listed in
Annex A.
The GMO Panel examined the results of the analysis of the 2014 farmer questionnaires on maize
MON 810, and acknowledges that there is no indication that unanticipated adverse effects have been
observed.
The GMO Panel notes that in the annual 2015 PMEM report of maize MON 810 approximately 2,500
farmers will have been surveyed over 10 years since the ﬁrst questionnaires were completed in 2006.
This is the total sample size determined by the consent holder (EFSA GMO Panel, 2011a) deemed
necessary to achieve sufﬁcient power to identify unanticipated adverse effects caused by maize
MON 810. The GMO Panel strongly recommends that the consent holder performs statistical analyses
pooling all the surveys obtained over the last 10 years and report the results of these analyses in the
annual 2015 PMEM report.
3.4. Existing monitoring networks
Directive 2001/18/EC and Council Decision 2002/811/EC propose to make use of existing
monitoring networks, as it complements farmer questionnaires and provides an additional tool for the
GS of GM plants. The Member States have various networks in place – some of which have a long
history of data collection – that may be helpful in the context of GS of GM plants. The networks
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involved in routine monitoring offer recognised expertise in a speciﬁc domain and have the tools to
capture information on important environmental aspects over a large geographical area.
The consent holder referred to an ongoing EuropaBio project that aims to map the existing
European monitoring networks, but that has not yet delivered information on possible networks that
could be involved in the GS of maize MON 810. Therefore, as in the previous annual PMEM reports,
the consent holder did not report information gathered by existing monitoring networks in the EU.
However, the GMO Panel notes that efforts have been made to develop a methodological framework to
facilitate the use of existing networks in the broader context of environmental monitoring (Centre for
Ecology and Hydrology et al., 2014; EFSA GMO Panel, 2014b; Smets et al., 2014). The GMO
Panel encourages that these efforts are continued by relevant parties (EFSA GMO Panel, 2011b).
3.5. Literature review
3.5.1. Relevant scientiﬁc publications reported by the consent holder
The consent holder performed a literature search to identify publications related to maize MON 810
and/or the Cry1Ab protein that were published in the peer-reviewed scientiﬁc literature between June
2014 and the beginning of June 2015.
The consent holder used Web of ScienceSM 26 as the only scientiﬁc literature database to identify
relevant publications.
The search terms27 used for the literature search were similar to those applied in the search
reported in the previous annual PMEM report (EFSA GMO Panel, 2015b). The GMO Panel considered
that the search terms used by the consent holder in its annual 2014 PMEM report are adequate to
retrieve relevant scientiﬁc publications. The search terms are broad and include synonyms (tolerant
and resistant), scientiﬁc and common names (maize and Zea mays), brand and generic names
(Yieldgard or Bt maize), British and US variants (maize and corn), etc. Boolean operators (i.e. OR,
AND) were appropriately used to combine terms, while wild card symbols allowed to retrieve variant
spellings (e.g. toleran*, protec*).
The consent holder initially identiﬁed 26 scientiﬁc relevant scientiﬁc papers published between June
2014 and the beginning of June 2015 (Appendix A): 25 publications were reported initially by the
consent holder in the 2014 annual PMEM report, and one additional publication (Zeljenkova et al.,
2014) was reported in the updated 2014 annual PMEM report.
Two publications were relevant to the molecular characterisation (MC) of maize MON 810, six
publications were relevant for the food and feed (FF) safety assessment (in terms of toxicity,
allergenicity and nutrition) and 18 publications pertained to the environmental risk assessment (ERA)
or risk management of maize MON 810 (mostly, studies assessing the interaction of maize MON 810
with target organisms (TOs) and non-target organisms (NTOs)). One of the MC-related publications,
Trtikova et al. (2015) had already been assessed by EFSA (EFSA, 2015b) concluding that the ﬁndings
reported by Trtikova et al. (2015) present no new scientiﬁc information that would invalidate the EFSA
GMO Panel’s previous risk assessment conclusions and recommendations on risk management of maize
MON 810.
The GMO Panel notes that 13 relevant scientiﬁc publications related to Bt-maize/maize MON 810
and/or the Cry1Ab protein (published between June 2014 and beginning June 2015) were not reported
by the consent holder (Appendix A) (see Section 3.5.2). Therefore, the GMO Panel makes the
following recommendations:
• to perform a more comprehensive systematic search by considering the EFSA Guidance
Document on systematic literature review methodology (EFSA, 2010) and to provide a protocol
for the systematic search that includes information on the date of the search, the full list of
retrieved scientiﬁc publications and clear criteria for exclusion/inclusion of relevant scientiﬁc
publications;
• to use additional scientiﬁc literature databases such as CAB Abstracts®,28 to increase the
likelihood to retrieve all relevant scientiﬁc publications (EFSA, 2015c).
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26 http://apps.webofknowledge.com/ (Accessed: 4 March 2016).
27 The list of keywords used to identify relevant scientiﬁc publications is given in Table 1 of the 2014 annual PMEM report on
maize MON 810.
28 http://www.cabi.org/publishing-products/online-information-resources/cab-abstracts/ (Accessed: 4 March 2016).
The GMO Panel encourages the consent holder to revise the protocol for the literature search
accordingly, and to supply it to EFSA annually.
The GMO Panel assessed all the scientiﬁc publications selected by the consent holder, and
acknowledges that these were adequately discussed and put into the context of the overall safety
assessment of maize MON 810.
The GMO Panel considers that none of the publications reported adverse effects of maize MON 810
on human and animal health or the environment.29
3.5.2. Additional scientiﬁc publications assessed by the GMO Panel
EFSA conducted a literature search to identify additional relevant scientiﬁc publications. Several
bibliographic databases were queried simultaneously to identify as many relevant peer-reviewed
scientiﬁc publications as possible. These were BIOSIS Citation IndexSM,30 CAB Abstracts®, Current
Contents Connect®,31 Medline®,32 and Web of Science Core CollectionTM.33 The databases were
integrated into Web of ScienceTM (Thomson Reuters, New York, NY, USA).
The literature search was performed using the same search terms and Boolean operators as the
consent holder, targeting scientiﬁc publications in the peer-reviewed scientiﬁc literature between June
2013 and June 2014 (which was the time interval covered by the literature search conducted by the
consent holder). The searches were subsequently reﬁned by selecting only those publications (as
document type) that were written in English.
The search was conducted on 4 November 2015 and identiﬁed a total of 351 references. References
were exported into an EndNote X5 database (Thomson Reuters) and duplicated references were
deleted. The 339 remaining scientiﬁc publications were screened and assessed manually by title and
abstract. Only peer-reviewed publications containing evidence speciﬁc to the risk assessment and/or
management of maize MON 810 were considered for further assessment.
The GMO Panel identiﬁed a total number of 39 relevant scientiﬁc publications (Appendix A), of
which 26 were reported by the consent holder in its annual 2014 PMEM report on maize MON 810 and
one (Hofmann et al., 2014) which was previously assessed by the GMO Panel (EFSA GMO Panel,
2015c). For this scientiﬁc publication, the GMO Panel concluded that the new information provided by
Hofmann et al. (2014) does not impact greatly on the mortality estimates for NT Lepidoptera of
conservation concern, occurring within protected habitats and potentially exposed to maize MON 810
pollen, and the previous recommendation for isolation distances around protected habitats, within
which maize MON 810 should not be cultivated, remains valid.
The remaining 12 scientiﬁc publications not previously assessed by EFSA or its GMO Panel are all
relevant for the ERA and/or risk management of maize MON 810. No additional scientiﬁc publications
relevant to the MC or FF safety assessment of maize MON 810 were identiﬁed.
The GMO Panel assessed the ERA-related scientiﬁc publications and concludes that no
environmental safety concerns owing to maize MON 810 or Cry1Ab were identiﬁed.
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29 In one of the scientiﬁc publications, Andreassen et al. (2015) investigated the immune responses (humoral and cellular) in
mice after airway exposure to Cry1Ab (test material: maize MON 810 pollen suspension, maize MON 810 leaf extracts, puriﬁed
Cry1Ab protoxin and trypsinised Cry1Ab). The authors reported no anti-Cry1Ab antibodies against the maize MON 810
materials tested. On the other hand, speciﬁc anti-Cry1Ab IgG1 and IgE were seen in the groups exposed to the puriﬁed
Cry1Ab protein (Cry1Ab protoxin or trypsinised Cry1Ab). The immunogenic capacity of the Cry1Ab protein per se is well-
known and it has been described in previous studies (Adel-Patient et al., 2011). This has been previously assessed by the
GMO Panel (EFSA GMO Panel, 2012b). Speciﬁc IgE antibodies against the puriﬁed Cry1Ab protein were observed by
Andreassen et al. (2015). The authors provided several hypotheses that in part might explain the difference in immune
responses to Cry1Ab observed in the different groups. Among the rational provided, structural differences between the Cry1Ab
proteins tested and differences in doses used were considered the main factors explaining the discrepancy in outcomes. The
GMO Panel agrees with the authors that, in order to elucidate these aspects, additional studies on the immunogenicity of
Cry1Ab proteins following an airway exposure would be useful. In the context of the risk assessment of maize MON 810, the
study by Andreassen et al. (2015) does not put forward new elements that would invalidate the previous conclusions on
maize MON 810 made by the GMO Panel. Speciﬁcally, no indications of safety concern due to the airway exposure of maize
MON 810 pollen suspension and maize MON 810 leaf extract in mice were identiﬁed.
30 http://wokinfo.com/products_tools/specialized/bci/ (Accessed: 4 March 2016).
31 http://thomsonreuters.com/en/products-services/scholarly-scientiﬁc-research/scholarly-search-and-discovery/current-contents-
connect.html (Accessed: 4 March 2016).
32 https://www.nlm.nih.gov/bsd/pmresources.html (Accessed: 4 March 2016).
33 http://thomsonreuters.com/en/products-services/scholarly-scientiﬁc-research/scholarly-search-and-discovery/web-of-science-
core-collection.html (Accessed: 4 March 2016).
3.5.3. Conclusions of the literature review
Results reported in the relevant peer-reviewed scientiﬁc publications included by the consent holder
in the annual 2014 PMEM report on maize MON 810 and additional ones identiﬁed by the GMO
Panel do not provide new information that would invalidate the previous FF and ERA conclusions on
maize MON 810 made by the Panel. Therefore, the GMO Panel considers that its previous conclusions
on the safety of maize MON 810 remain valid and applicable (EFSA, 2009; EFSA GMO Panel, 2012b,c).
4. Conclusions
The data reported in the annual 2014 PMEM report on maize MON 810 do not indicate any
adverse effects on human and animal health or the environment arising from the cultivation of maize
MON 810 during the 2014 growing season. The GMO Panel therefore concludes that the CSM and
GS of maize MON 810 as carried out by the consent holder did not provide evidence that would
invalidate previous GMO Panel evaluations on the safety of maize MON 810 (EFSA, 2009; EFSA GMO
Panel, 2012b,c). However, the GMO Panel identiﬁed limitations that need further action from the
consent holder.
5. Recommendations
5.1. Case-speciﬁc monitoring
The GMO Panel considers that the detection levels of resistance allele frequency in target pest
populations set by risk managers should consider sufﬁcient time to implement appropriate mitigation
measures to prevent ﬁeld resistance and sample sizes (i.e. number of larvae to be screened). The
GMO Panel is of the opinion that the sample size of target pest populations needs to be proportionate
to the detection levels of resistance allele frequency set by risk managers.
The GMO Panel considers that a detection level of 1% would be an appropriate threshold because
it would give more time to undertake mitigation measures and offers more options to reduce the
potential for ﬁeld resistance to evolve than a detection level of 3%. However, owing to practical
sampling limitations, the GMO Panel recommends that a threshold of 3% should be achieved in
practice, meaning that the minimum number of ﬁeld larvae tested should be above ca. 1,000 in a
given sampling area in those regions where the adoption rates of maize MON 810 are above 60%,
such as the Ebro valley. If achievable, a lower detection limit should be aimed at by the consent
holder.
The GMO Panel maintains its previous recommendation to perform annual monitoring of
bi-/multivoltine target pests when adoption rate of maize MON 810 is higher than 60% in order to
ensure early detection of change in susceptibility of the ECB and MCB ﬁeld populations.
While adoption rates remain low in other regions growing maize MON 810, the GMO
Panel recommends focusing the sampling effort exclusively in North East Iberia (i.e. the Ebro valley),
where ﬁeld resistance to Cry1Ab is more likely to develop. In that geographical area, samples should
be collected in three zones of approximately 10 km 9 10 km, where adoption rate of maize MON 810
is higher than 50% for at least three consecutive years. The consent holder should clearly identify
cases where larger zones are required to ensure that sufﬁcient numbers of larvae are collected. In
order to acquire information on maize MON 810 cropping areas, the GMO Panel reiterates the
importance for the Member States to implement national GMO cultivation registers, as referred to in
Article 31.3 (b) of Directive 2001/18/EC.
For all sampling sites, the consent holder is encouraged to provide the geographical coordinates.
Samples from each sampling zone should be analysed separately in order to detect potential
interpopulation variation in the susceptibility of target pest populations.
The GMO Panel considers that the consent holder should provide more information on the farmer
alert system (e.g. number and type of complaints, how complaints referring to potential lack of
efﬁcacy of maize MON 810 are followed up by the consent holder, how complaints to other consent
holders marketing maize MON 810 are collated and analysed) in order to determine whether
appropriate communication mechanisms and ﬁt-for-purpose educational programmes are in place to
ensure timely and effective reporting of farmer complaints regarding product performance.
The GMO Panel recommends that further details on the methodology (e.g. preimaginal mortality of
ﬁeld-collected larvae, number of adults mated to obtain F1 larvae, number of individuals screened and
number of replicates in the diagnostic dose assay) in the laboratory bioassays should be provided for
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an appropriate estimation of the detection limit of resistance allele frequency. Regarding the dose–
response bioassays to assess changes in susceptibility to Cry1Ab, the GMO Panel reiterates its previous
recommendations to provide both LC and MIC values in the future PMEM reports.
Considering the implementation of non-Bt refugia, the GMO Panel recommends that the consent
holder consolidates its efforts to increase the level of compliance, especially in regions of high maize
MON 810 adoption.
5.2. General surveillance
The GMO Panel identiﬁed shortcomings in the methodology followed by the consent holder to
analyse the farmer questionnaires similar to those found in previous reports. Therefore, the
Panel reiterates its recommendations on the survey design and reporting to provide more detailed
information on the sampling methodology and to reduce the possibility of selection bias (for further
details on the recommendations, see Annex A), as this would give more conﬁdence in the conclusion
on the absence of adverse effects. In order to improve the sampling frame of the farmer survey, the
GMO Panel reiterates the importance of national GMO cultivation registers and its recommendations to
consent holders to consider how they may make best use of the information recorded in national
registers and foster dialogue with those responsible for the administration of the registers of maize
MON 810 cultivation.
The outcome of the literature review conﬁrms the previous conclusions on the safety of maize
MON 810 made by the GMO Panel. In addition, considering the relevant publications identiﬁed as
missing, the GMO Panel advises the consent holder to improve the methodology followed in the
literature review to ensure that all relevant publications are identiﬁed and assessed (e.g. following
the EFSA guidance on systematic reviews (EFSA, 2010), use of additional databases, providing
inclusion/exclusion criteria). Moreover, the consent holder is requested to continue screening,
reviewing and discussing relevant scientiﬁc publications on possible adverse effects of maize
MON 810 on rove beetles as previously recommended by the GMO Panel (EFSA GMO Panel,
2014a).
No information collected from existing monitoring networks in the EU was provided by the consent
holder. However, the GMO Panel notes that initiatives have been taken to develop a methodological
framework to use existing networks in the broader context of environmental monitoring and
encourages the relevant parties to continue to develop these.
Documentation provided to EFSA
1) Letter from the European Commission, dated 26 October 2015, to the EFSA Executive Director
requesting the assessment of the annual 2014 PMEM report on maize MON 810 cultivation
during the 2014 growing season report provided by Monsanto; the PMEM report was annexed
to the letter.
2) Comments from the Member States on the annual 2014 PMEM report on the cultivation of
maize MON 810 during the 2014 growing season.
3) Acknowledgement letter, dated 13 November 2015, from the EFSA Executive Director to the
European Commission.
4) Considerations from the National Committee of Biosafety of the Spanish Competent Authority
expressed EFSA recommendations on the IRM plan for maize MON 810.
5) Email from the European Commission, dated 3 February 2016, to the GMO Unit requesting the
assessment of an additional scientiﬁc publication.
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Abbreviations
Bt Bacillus thuringiensis
CSM case-speciﬁc monitoring
ECB European corn borer
AMU Unit EFSA Unit for Assessment and Methodological Support
GMO Panel EFSA Panel on Genetically Modiﬁed Organisms
ERA environmental risk assessment
FF food and feed
GM genetically modiﬁed
GMO genetically modiﬁed organism
GS general surveillance
IRM insect resistance management
LC lethal concentration
LT50 median lethal time
MC molecular characterisation
MCB Mediterranean corn borer
MIC moulting inhibitory concentration
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NT non-target
NTO non-target organism
PMEM post-market environmental monitoring
SE standard error
TO target organism
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Annex A – EFSA AMU Unit technical report on the evaluation of farmer
questionnaires
Annex A can be found in the online version of this output: http://dx.doi.org/10.2903/
j.efsa.2016.4446
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